Corporate News 05-Jul-22
Biocon Biologics receives EU GMP certificate for new facility in Bengaluru
Biocon announced that its subsidiary, Biocon Biologics has received a EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru, following a GMP inspection in April 2022.
Previous News
Biocon to conduct board meeting
( Corporate News - 18-Jul-24 10:37 )
Biocon AGM scheduled
( Corporate News - 17-May-24 13:47 )
Indices trade with decent gains; realty shares rallied for 5th day
( Market Commentary - Mid-Session 17-May-24 12:40 )
Biocon issues corporate guarantee of $20 mn for Biocon Generics
( Corporate News - 24-Feb-24 12:47 )
Biocon reports consolidated net profit of Rs 660.00 crore in the December 2023 quarter
( Results - Announcements 09-Feb-24 07:41 )
Biocon Ltd eases for fifth straight session
( Hot Pursuit - 25-Oct-23 13:35 )
Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
( Corporate News - 09-Nov-23 09:15 )
Biocon
( Results - Analysis 13-Nov-23 12:15 )
Biocon CFO resigns
( Corporate News - 08-Feb-24 19:43 )
Biocon announces resignation of senior management
( Corporate News - 08-Feb-24 19:49 )
Biocon says USFDA issues CRL for biologics license application for Bevacizumab
( Hot Pursuit - 13-Feb-23 08:32 )
Other Stories
ADC India Communications to table results
07-Oct-24 14:08
Havells India to discuss results
07-Oct-24 14:07
Julien Agro Infratech announces board meeting date
07-Oct-24 14:07
Pondy Oxides & Chemicals schedules board meeting
07-Oct-24 14:07
Pakka schedules board meeting
07-Oct-24 14:07
Gangotri Textiles to conduct board meeting
07-Oct-24 14:07
Lakshmi Electrical Control Systems to conduct board meeting
07-Oct-24 14:06
BEW Engg.to consider bonus issue
07-Oct-24 14:06
Elecon Engineering Company declare Quarterly Result
07-Oct-24 14:06
Gujarat Gas to convene board meeting
07-Oct-24 14:06
Back
Top
